NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD
ARCA biopharma, Inc. (ABIO) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
